Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC

Clinical trial NCT07038629 · RECRUITING

Trial details

NCT number: NCT07038629
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2025-09-08
Primary completion: 2026-09-30
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.